Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Toxicity of Sn-pyrophosphate: clinical manifestations prior to acute LD$sub 50$

Journal Article · · J. Nucl. Med., v. 15, no. 4, pp. 252-256
OSTI ID:4310314
Following the administration of large amounts of technetiumSn-phosphate compounds in rats, tetany appears to be the primary clinical manifestation. To evaluate this phenomenon, acute LD/sub 50/ (5 min) was determined and serum calcium and arterial plasma pCO/sub 2/were measured and related to the administered dose. The LD/sub 50/ (5 min) for pyrophosphate was found to be 41.0 plus or minus 1.6 mg/kg (2 s.d.) body weight whereas the LD/sub 50/ (5 min) for polyphosphate was found to be 29.4 plus or minus 2.0 mg/kg (2 s.d.) body weight. There was no significant difference between the slopes of the two compounds. When acute LD/sub 50/s are compared, polyphosphate was 1.4 times more toxic than pyrophosphate. Arterial blood pCO/sub 2/ remained between 30 and 40 Torr until doses of pyrophosphate exceeded 35 mg/kg body weight, after which it fell sharply. Serum calcium concentration was monitored by atomic absorption spectroscopy and electrocardiography. There was a significant drop in the ionized and bound calcium concentrations beginning at an adrministered dose of 20 mg/kg body weight. Electrocardiographic changes consistent with hypocalcemia were recognized after injection of 12 mg/kg body weight. Howevcr, tetany was not apparent until 22 mg/ kg body weight of pyrophosphate was given. Therefore, evaluation of the toxic effects of phosphate agents should not be limited to determination of LD/sub 50/ alone but should include appropriate biochemical measurements in blood. (auth)
Research Organization:
Armed Forces Radiobiology Research Inst., Bethesda, MD
NSA Number:
NSA-29-029931
OSTI ID:
4310314
Journal Information:
J. Nucl. Med., v. 15, no. 4, pp. 252-256, Journal Name: J. Nucl. Med., v. 15, no. 4, pp. 252-256; ISSN JNMEA
Country of Publication:
Country unknown/Code not available
Language:
English

Similar Records

SAS probit analysis for cadmium mortality
Journal Article · Fri Oct 01 00:00:00 EDT 1982 · Environ. Res.; (United States) · OSTI ID:5695660

Bone and parathyroid inhibitory effects of S-2(3-aminopropylamino)ethylphosphorothioic acid. Studies in experimental animals and cultured bone cells
Journal Article · Sun Mar 31 23:00:00 EST 1985 · J. Clin. Invest.; (United States) · OSTI ID:5123983

Hypocalcemia and inhibition of parathyroid hormone secretion after administration of WR-2721 (a radioprotective and chemoprotective agent)
Journal Article · Wed Nov 09 23:00:00 EST 1983 · N.Engl. J. Med.; (United States) · OSTI ID:7011611